JPRN-UMIN000008979
Recruiting
N/A
effect of biochemical markers of bone turnover for treating and predicting fracture risk risk of metabolic bone disease - effect of biochemical markers of bone turnover for treating and predicting fracture risk risk of metabolic bone disease
Osaka City University Graduate School of Medicine0 sites400 target enrollmentOctober 1, 2012
Conditionsosteoporosis
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- osteoporosis
- Sponsor
- Osaka City University Graduate School of Medicine
- Enrollment
- 400
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patient who has been already treated with medicine for osteoporosis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
effect of biochemical markers of bone turnover for predicting fracture risk and changes of the bone mineral density in a long-term cohort studyosteopeniaJPRN-UMIN000008977Osaka City University Graduate School of Medicine300
Completed
N/A
Measurement of biochemical markers of bone turnover in patients with bilateral sagittal split osteotomybone specific markers in urine and serum10005959NL-OMON36318niversitair Medisch Centrum Groningen20
Active, Not Recruiting
Phase 1
A Study to investigate Bone turnover Markers in patients planned to receive tofacitinibRheumatoid arthritisMedDRA version: 20.0 Level: PT Classification code 10039073 Term: Rheumatoid arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2018-003162-13-ITAZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA30
Unknown
Phase 4
Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic PatientsOsteoporosisNCT02156960Shinshu University100
Completed
N/A
Study on the effect on bone metabolism markers of ARB combination drug that targets high blood pressure patientsHypertensionJPRN-UMIN000014135Saitama Medical University30